Cubist Systematic Strategies’s Cymabay Therapeutics CBAY Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-62,516
| Closed | -$932K | – | 2783 |
|
2023
Q3 | $932K | Buy |
62,516
+10,771
| +21% | +$161K | 0.01% | 1067 |
|
2023
Q2 | $567K | Sell |
51,745
-479,636
| -90% | -$5.25M | ﹤0.01% | 1363 |
|
2023
Q1 | $4.63M | Buy |
531,381
+478,052
| +896% | +$4.17M | 0.03% | 647 |
|
2022
Q4 | $334K | Sell |
53,329
-112,916
| -68% | -$708K | ﹤0.01% | 2399 |
|
2022
Q3 | $582K | Buy |
166,245
+114,911
| +224% | +$402K | ﹤0.01% | 2409 |
|
2022
Q2 | $151K | Buy |
51,334
+17,654
| +52% | +$51.9K | ﹤0.01% | 3283 |
|
2022
Q1 | $105K | Buy |
33,680
+9,189
| +38% | +$28.6K | ﹤0.01% | 3206 |
|
2021
Q4 | $83K | Buy |
24,491
+5,778
| +31% | +$19.6K | ﹤0.01% | 3237 |
|
2021
Q3 | $68K | Sell |
18,713
-44,987
| -71% | -$163K | ﹤0.01% | 2799 |
|
2021
Q2 | $278K | Sell |
63,700
-87,740
| -58% | -$383K | ﹤0.01% | 2383 |
|
2021
Q1 | $688K | Buy |
151,440
+73,861
| +95% | +$336K | 0.01% | 1776 |
|
2020
Q4 | $445K | Buy |
77,579
+20,613
| +36% | +$118K | 0.01% | 1833 |
|
2020
Q3 | $412K | Buy |
56,966
+41,130
| +260% | +$297K | 0.01% | 1856 |
|
2020
Q2 | $55K | Buy |
15,836
+2,577
| +19% | +$8.95K | ﹤0.01% | 2264 |
|
2020
Q1 | $20K | Sell |
13,259
-7,762
| -37% | -$11.7K | ﹤0.01% | 2065 |
|
2019
Q4 | $41K | Sell |
21,021
-14,075
| -40% | -$27.5K | ﹤0.01% | 2294 |
|
2019
Q3 | $180K | Buy |
35,096
+14,001
| +66% | +$71.8K | ﹤0.01% | 1814 |
|
2019
Q2 | $151K | Buy |
+21,095
| New | +$151K | ﹤0.01% | 2154 |
|
2019
Q1 | – | Sell |
-26,897
| Closed | -$212K | – | 2460 |
|
2018
Q4 | $212K | Buy |
26,897
+20,099
| +296% | +$158K | 0.01% | 1495 |
|
2018
Q3 | $75K | Sell |
6,798
-2,105
| -24% | -$23.2K | ﹤0.01% | 1632 |
|
2018
Q2 | $119K | Sell |
8,903
-14,866
| -63% | -$199K | 0.01% | 1487 |
|
2018
Q1 | $309K | Buy |
+23,769
| New | +$309K | 0.02% | 1126 |
|